For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Hims & Hers has seen a recent sell-off due to short-term turbulence but is set to recover with strong growth potential. Find ...

WASHINGTON — For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as ...

San Francisco’s gourmet doughnut cafe George’s Donuts & Merriment is receiving online backlash just weeks after opening due to a sizable donation its co-owner’s startup made to President Donald ...

Hims & Hers is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers.

Hims & Hers (NYSE: HIMS) is adding another specialty in an effort to build out its healthcare platform. The company has brought testosterone to the market, the first big addition since weight loss in ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published ...

When you're ready to invest, check out this top 10 list of stocks to buy. A full transcript is below. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst ...